Free Trial
NASDAQ:ZLAB

Zai Lab (ZLAB) Stock Price, News & Analysis

Zai Lab logo
$28.48 -0.36 (-1.26%)
As of 09:33 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Zai Lab Stock (NASDAQ:ZLAB)

Advanced

Key Stats

Today's Range
$28.48
$28.48
50-Day Range
$28.40
$35.73
52-Week Range
$23.82
$44.34
Volume
4,076 shs
Average Volume
916,358 shs
Market Capitalization
$3.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.35
Consensus Rating
Moderate Buy

Company Overview

Zai Lab Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

ZLAB MarketRank™: 

Zai Lab scored higher than 56% of companies evaluated by MarketBeat, and ranked 499th out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zai Lab has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 6 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Zai Lab has a consensus price target of $56.35, representing about 95.4% upside from its current price of $28.84.

  • Amount of Analyst Coverage

    Zai Lab has only been the subject of 3 research reports in the past 90 days.

  • Read more about Zai Lab's stock forecast and price target.
  • Earnings Growth

    Earnings for Zai Lab are expected to grow in the coming year, from ($2.58) to ($1.74) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zai Lab is -14.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zai Lab is -14.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zai Lab has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Zai Lab's valuation and earnings.
  • Percentage of Shares Shorted

    4.38% of the outstanding shares of Zai Lab have been sold short.
  • Short Interest Ratio / Days to Cover

    Zai Lab has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Zai Lab has recently increased by 0.41%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Zai Lab does not currently pay a dividend.

  • Dividend Growth

    Zai Lab does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.38% of the outstanding shares of Zai Lab have been sold short.
  • Short Interest Ratio / Days to Cover

    Zai Lab has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Zai Lab has recently increased by 0.41%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Zai Lab has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Zai Lab this week, compared to 7 articles on an average week.
  • Search Interest

    5 people have searched for ZLAB on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zai Lab insiders have sold 1,854.43% more of their company's stock than they have bought. Specifically, they have bought $289,100.00 in company stock and sold $5,650,256.00 in company stock.

  • Percentage Held by Insiders

    Only 4.96% of the stock of Zai Lab is held by insiders.

  • Percentage Held by Institutions

    41.65% of the stock of Zai Lab is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zai Lab's insider trading history.
Receive ZLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zai Lab and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZLAB Stock News Headlines

Zai Lab Secures RMB300 Million Debt Facility
The Army Just Got a New Drone Supplier
A cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a full FPV ecosystem — training troops, supporting operations overseas, and expanding America’s battlefield tech edge.tc pixel
Zai Lab falls -6.9%
See More Headlines

ZLAB Stock Analysis - Frequently Asked Questions

Zai Lab's stock was trading at $26.19 at the beginning of 2025. Since then, ZLAB stock has increased by 10.1% and is now trading at $28.84.

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) issued its earnings results on Thursday, August, 7th. The company reported ($0.37) EPS for the quarter, hitting the consensus estimate of ($0.37). The firm had revenue of $109.98 million for the quarter, compared to the consensus estimate of $125.66 million. Zai Lab had a negative trailing twelve-month return on equity of 27.32% and a negative net margin of 49.68%.
Read the conference call transcript
.

Zai Lab (ZLAB) raised $100 million in an initial public offering (IPO) on Wednesday, September 20th 2017. The company issued 5,900,000 shares at $16.00-$18.00 per share. J.P. Morgan, Citigroup and Leerink Partners served as the underwriters for the IPO.

Shares of ZLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zai Lab investors own include NVIDIA (NVDA), Tesla (TSLA), Intel (INTC), Meta Platforms (META), Advanced Micro Devices (AMD), Baidu (BIDU) and Home Depot (HD).

Company Calendar

Last Earnings
8/07/2025
Today
10/16/2025
Next Earnings (Confirmed)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZLAB
CIK
1704292
Employees
1,869
Year Founded
2014

Price Target and Rating

High Price Target
$75.00
Low Price Target
$36.10
Potential Upside/Downside
+95.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$257.10 million
Net Margins
-49.68%
Pretax Margin
-49.68%
Return on Equity
-27.32%
Return on Assets
-18.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.12
Quick Ratio
2.93

Sales & Book Value

Annual Sales
$398.99 million
Price / Sales
8.08
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.68 per share
Price / Book
3.76

Miscellaneous

Outstanding Shares
111,760,000
Free Float
106,220,000
Market Cap
$3.22 billion
Optionable
Optionable
Beta
1.08

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ZLAB) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners